Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy

被引:386
作者
Demark-Wahnefried, W
Peterson, BL
Winer, EP
Marks, L
Aziz, N
Marcom, PK
Blackwell, K
Rimer, BK
机构
[1] Duke Univ, Med Ctr, Durham, NC 27710 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA
关键词
D O I
10.1200/JCO.2001.19.9.2381
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Weight gain is a common problem among breast cancer patients who receive adjuvant chemotherapy (CT). We undertook a study to determine the causes of this energy imbalance. Patients and Methods: Factors related to energy balance were assessed at baseline (within 3 weeks of diagnosis) and throughout 1 year postdiagnosis among 53 premenopausal women with operable breast carcinoma, Thirty-six patients received CT and 17 received only localized treatment (LT). Measures included body composition (dual energy x-ray absorptiometry), resting energy expenditure (REE; indirect calorimetry), dietary intake (2-day dietary recalls and food frequency questionnaires) and physical activity (physical activity records). Results: Mean weight gain in the LT patients was 1.0 kg versus 2.1 kg in the CT group (P = .02), No significant differences between groups in trend over time were observed for REE and energy intake; however, a significant difference was noted for physical activity (P = .01). Several differences between groups in 1-year change scores were detected. The mean change (+/- SE) in LT versus CT groups and P values for uncontrolled/ controlled (age, race, radiation therapy, baseline body mass index, and end point under consideration) analysis are as follows: percentage of body fat (-0.1 +/- 0.4 v +2.2 +/- 0.6%; P = .001/0.04); fat mass (+0.1 +/- 9.3 v +2.3 +/- 0.7 kg; P = .002/0.04); lean body mass (+0.8 +/- 0.2 v +/- 0.4 +/- 0.3 kg; P = .02/0.30); and leg lean mass (+/- 0.5 +/- 0.1 v -0.2 +/- 0. 1 kg; P = .01/0.11). Conclusion: These data do not support overeating as a cause of weight gain among breast cancer patients who receive CT. The data suggest, however, that CT-induced weigh, gain is distinctive and indicative of sarcopenic obesity (weight gain in the presence of lean tissue loss or absence of lean tissue gain). The development of sarcopenic obesity with evidence of reduced physical activity supports the need for interventions focused on exercise, especially resistance training in the lower body, to prevent weight gain. J Clin Oncol 19:2381-2389. (C) 2001 by American Society of Clinical Oncology.
引用
收藏
页码:2381 / 2389
页数:9
相关论文
共 51 条
[1]   COMPENDIUM OF PHYSICAL ACTIVITIES - CLASSIFICATION OF ENERGY COSTS OF HUMAN PHYSICAL ACTIVITIES [J].
AINSWORTH, BE ;
HASKELL, WL ;
LEON, AS ;
JACOBS, DR ;
MONTOYE, HJ ;
SALLIS, JF ;
PAFFENBARGER, RS .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1993, 25 (01) :71-80
[2]   Changes in body composition during breast cancer chemotherapy with the CMF-regimen [J].
Aslani, A ;
Smith, RC ;
Allen, BJ ;
Pavlakis, N ;
Levi, JA .
BREAST CANCER RESEARCH AND TREATMENT, 1999, 57 (03) :285-290
[3]   Changes in body composition during adjuvant chemotherapy for breast cancer [J].
Aslani, A ;
Smith, RC ;
Allen, BJ ;
Levi, JA .
APPLIED RADIATION AND ISOTOPES, 1998, 49 (5-6) :637-638
[4]   NUTRITION AND BREAST-CANCER [J].
BOYD, NF .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (01) :6-7
[5]   NONCANCER DEATHS IN WHITE ADULT CANCER-PATIENTS [J].
BROWN, BW ;
BRAUNER, C ;
MINNOTTE, MC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (12) :979-987
[6]   WEIGHT CHANGE IN WOMEN TREATED WITH ADJUVANT THERAPY OR OBSERVED FOLLOWING MASTECTOMY FOR NODE-POSITIVE BREAST-CANCER [J].
CAMORIANO, JK ;
LOPRINZI, CL ;
INGLE, JN ;
THERNEAU, TM ;
KROOK, JE ;
VEEDER, MH .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (08) :1327-1334
[7]   Computerized tomography assessment of women with weight changes associated with adjuvant treatment for breast cancer [J].
Cheney, CL ;
Mahloch, J ;
Freeny, P .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 66 (01) :141-146
[8]   LONG-TERM SURVIVAL FOLLOWING RELAPSE AFTER 5-FU BUT NOT CMF ADJUVANT BREAST-CANCER THERAPY [J].
CHLEBOWSKI, RT ;
WEINER, JM ;
REYNOLDS, R ;
LUCE, J ;
BULCAVAGE, L ;
BATEMAN, JR .
BREAST CANCER RESEARCH AND TREATMENT, 1986, 7 (01) :23-29
[9]  
Coates RJ, 1999, AM J EPIDEMIOL, V149, P1104, DOI 10.1093/oxfordjournals.aje.a009764
[10]   Fruit and vegetable intakes and prostate cancer risk [J].
Cohen, JH ;
Kristal, AR ;
Stanford, JL .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (01) :61-68